| deltaparin versus control | |||
| Michot, 2002 | deltaparin 2500IU 60-120min before procedure, followed 6hrs after the end of the procedure by 2500IU (<70kg) or 5000 IU(>70kg) versus no treatment | patients requiring diagnostic or therapeutic arthoscopic knee surgery as outpatients; aged18 to 80 years. | open Follow-up duration: 30 days Switzerland. |
| enoxaparin versus control | |||
| Canata, 2003 | enoxaparin sc daily (dose not specified) versus no treatment | ACL reconstruction for symptomatic ACL-deficient knees | Follow-up duration: 6 days Italy |
| extended-duration thromboprophylaxis versus standard-duration thromboprophylaxis | |||
| Marlovits, 2007 | extended-duration thromboprophylaxis with enoxaparin for 20 days versus standard thromboprophylaxis with enoxaparin (3 to 8 days) | patients who had undergone arthroscopic surgery of the anterior cruciate ligament | double-blind Follow-up duration: <=28 days Austria |
| nadroparin versus control | |||
| KANT (7 days), 2008 | once-daily subcutaneous injection of LMWH (nadroparin, 3800 anti-Xa IU) for 7 days versus full-length graduated compression stocking for 7 days | patients undergoing knee arthroscopy | open (blinded assessment) Follow-up duration: 3 months Italy |
| Roth, 1995 | 0.3 ml sc fraxiparine 2 hours before the operation and self administered daily (except the firstvtwo doses) for 4 days after surgeryn/x versus no treatment | patients undergoing ambulatory arthroscopic | Follow-up duration: 4 days Germany |
| nadroparin 14d versus control | |||
| KANT (14 days), 2008 | once-daily subcutaneous injection of LMWH (nadroparin, 3800 anti-Xa IU) for 14 days versus full-length graduated compression stocking for 7 days | patients undergoing knee arthroscopy | open (blinded assessment) Follow-up duration: 3 months Italy |
| reviparin versus control | |||
| Wirth, 2001 | reviparin 1,750 anti Xa IU Sc once daily for 7-10 days versus no treatment | elective knee arthroscopy | open (blind assessement) Follow-up duration: 7-10 days Germany |
in first
in second
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
